Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma

Objective: The aim of our retrospective study was to evaluate pathological changes in adenomyotic foci in hysterectomy specimens, and point out a possible mechanism of carcinogenesis in adenomyotic foci inside the myometrium. Methods: Retrospective analysis of clinical data; 219 patients were operated at our departments from 2003-2008 with the diagnosis of early endometrial cancer. Standard staging operation was used in all cases and all hysterectomy specimens were afterwards routinely analyzed. Results: Adenomyosis was found in 88 of a total of 219 hysterectomy specimens, while 205 of these 219 were affected by endometrioid adenocarcinoma, ten with clear cell carcinoma and four with papillary serous carcinoma. Within these subgroups adenomyosis was documented in 87 of 205 specimens with endometrioid adenocarcinoma (42.4%) and in one specimen of ten with clear cell carcinoma (2.2%), all found in the eutopic endometrium. All cases of malignant changes (n = 6) in adenomyosis were found exclusively with coexisting endometrioid adenocarcinoma: adenocarcinoma in adenomyosis was well or moderately differentiated in five cases, and poorly differentiated in just one case. Differentiation of the tumor in adenomyosis correlated with differentiation of the eutopic endometrial cancer in 50%. Hyperplastic changes like benign glandular hyperplasia, or atypical complex hyperplasia (ACH) were identified simultaneously in all cancer-positive adenomyotic foci. Conclusion: Malignant changes in adenomyosis were present in 6.8% of patients with endometrial cancer. All malignancy-positive cases of adenomyosis were associated with endometrioid adenocarcinoma of the eutopic endometrium. Interestingly, in all these cases, different stages of hyperplastic changes were also simultaneously identified. This observation suggests a similar pathway of carcinogenesis in adenomyosis as is known in estrogen-responsive endometrial cancer type I.

Hysterectomy; Myometrium; Adenomyosis; Endometrial cancer; Adenocarcinoma; Carcinogenesis

[1] Bergeron C., Amant F., Ferenczy A.: “Pathology and physiopathology of adenomyosis”. Best Pract. Res. Clin. Obstet. Gynaecol., 2006, 20, 511.

[2] Hever A., Roth R.B., Hevezi P.A., Lee J., Willhite D., White E.C. et al.: “Molecular characterization of human adenomyosis”. Mol. Hum. Reprod., 2006, 12, 737.

[3] Kairi-Vassilatou E., Kontogianni K., Salamalekis M., Sykiotis K., Kondi-Pafitis A.: “A clinicopathological study of the relationship between adenomyosis and other hormone-dependent uterine lesions”. Eur. J. Gynaecol. Oncol., 2004, 25, 222.

[4] Matalliotakis I.M., Kourtis A.I., Panidis D.K.: “Adenomyosis”. Obstet. Gynecol. Clin. North Am., 2003, 30, 63.

[5] Kitawaki J.: “Adenomyosis: the pathophysiology of an oestrogen-dependent disease”. Best Pract. Res. Clin. Obstet. Gynaecol., 2006, 20, 493.

[6] Ronnett B.M., Zaino R.J., Ellenson L.H., Kurman R.J.: “Endometrial carcinoma”. In: Blaustein’s Pathology of the Female Genital Tract, 5th edition, Kurman R.J. (ed.), New York, Springer-Verlag, 2002, 501.

[7] Akahane T., Sekizawa A., Purwosunu Y., Nagatsuka M., Okai T.: “The role of p53 mutation in the carcinomas arising from endometriosis”. Int. J. Gynecol. Pathol., 2007, 26, 345.

[8] Hsu M.I., Chou S.Y., Lin S.E., Liang S.J., Chiu H.C., Hsu C.S.: “Very early stage adenocarcinoma arising from adenomyosis in the uterus”. Taiwan J. Obstet. Gynecol., 2006, 45, 346.

[9] Motohara K., Tashiro H., Ohtake H., Saito F., Ohba T., Katabuchi H.: “Endometrioid adenocarcinoma arising in adenomyosis:elucidation by periodic magnetic resonance imaging evaluations”. Int. J. Clin. Oncol., 2008, 13, 266.

[10] Puppa G., Shozu M., Perin T., Nomura K., Gloghini A., Campagnutta E. et al.: “Small adenocarcinoma in adenomyosis with nodal metastasis: a case report”. BMC Cancer, 2007, 7, 103.

[11] Sasaki T., Sugiyama T., Nanjo H., Hoshi N., Murakami M., Sugita A. et al.: “Endometrioid adenocarcinoma arising from adenomyosis: report and immunohistochemical analysis of an unusual case”. Pathol. Int., 2001, 51, 318.

[12] Ismiil N., Rasty G., Ghorab Z., Nofech-Mozes S., Bernardini M., Thomas G. et al.: “Adenomyosis is associated with myometrial invasion by FIGO I endometrial adenocarcinoma”. Int. J. Gynecol. Pathol., 2007, 26, 278.

[13] Ismiil N., Rasty G., Ghorab Z., Nofech-Mozes S., Bernardini M., Ackerman I. et al.: “Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion”. Ann. Diagn. Pathol., 2007, 11, 252.

[14] Koshiyama M., Suzuki A, Ozawa M., Fujita K., Sakakibara A., Kawamura M. et al.: “Adenocarcinoma arising from uterine adenomyosis: a report of four cases”. Int. J. Gynecol. Pathol., 2002, 21, 239.

[15] Mittal K.R., Barwick K.W.: “Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preciding estrogen therapy, low histologic grades, and excellent prognosis”. Gynecol. Oncol., 1993, 49,197.

[16] Hall J.B., Young R.H., Nelson J.H.: “The prognostic significance of adenomyosis in endometrial carcinoma”. Gynecol. Oncol.,1984, 17, 32.

[17] McCluggage W.G., Robboy S.J.: “Mesenchymal uterine tumors, other than pure smooth muscle neoplazma, and adenomyosis”. In: Robboy S.J. (ed.). Robboy’s Pathology of the Female Reproductive Tract. 2nd edition. London, Churchill Livingstone Elsevier, 2009, 427.

[18] Colman H.I., Rosenthal A.H.: “Carcinoma developing in area of adenomyosis”. Obstet. Gynecol., 1959, 14, 342.

[19] Fujiwara H., Nishisaka T., Urabe T., Miyoshi H., Kudo Y.: “Stromal reaction of adenomyosis protects from uterine endometrial cancer invasion to myometrium”. J. Clin. Oncol., 2007 ASCO Annual Meeting Proceedings, 25, 16064.

[20] Koshiyama M., Okamoto T., Ueta M.: “The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri”. Cancer Detect. Prev., 2004, 28, 94.

[21] Taskin M., Lallas T.A., Shevcuk M., Barber H.R.K.: “P53 expression in adenomyosis in endometrial carcinoma patients”. Gynecol. Oncol., 1996, 62, 241.

[22] Kucera E., Hejda V., Turyna R., Otcenasek,M., Drahonovsky J., Feyereisl J.: “Accuracy of intraoperative frozen section during laparoscopic management of early endometrial cancer”. Eur. J. Gynaecol. Oncol., 2009, 30, 408

[23] Kir G., Kir M., Cetiner H., Karateke A., Gurbuz A.: “Diagnostic problems on frozen section examination of myometrial invasion in patients with endometrial cancer with special emphasis on the pitfalls of deep adenomyosis with cancerous involvement”. Eur. J. Gynaecol. Oncol., 2004, 25, 211.